Ornithine Transcarbamylase (OTC) Deficiency Treatment Market
6 mins read
Ornithine Transcarbamylase (OTC) Deficiency Treatment Market projected to expand at a CAGR of ~4% from 2020 to 2030
Ornithine Transcarbamylase (OTC) Deficiency Treatment Market: Introduction According to the report, the global ornithine transcarbamylase (OTC) deficiency treatment market was valued at ~US$ 600 Mn in 2019. It is projected to expand at a CAGR of ~4% from 2020 to 2030. Ornithine transcarbamylase (OTC) deficiency is a rare X-linked genetic disorder characterized by partial or complete lack of the […]